These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7135344)

  • 21. The efficacy and potency of antiplatelet activity of ticlopidine is increased by aspirin.
    Splawinska B; Kuzniar J; Malinga K; Mazurek AP; Splawinski J
    Int J Clin Pharmacol Ther; 1996 Aug; 34(8):352-6. PubMed ID: 8864799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ticlopidine activity on platelet function in patients with enhanced platelet aggregation. A short-term crossover study.
    Gensini GF; Favilla S; Breschi C; Abbate R; Costanzo G; Neri Serneri GG
    Haemostasis; 1983; 13(5):294-300. PubMed ID: 6228500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet inhibitory activity and pharmacokinetics of prasugrel (CS-747) a novel thienopyridine P2Y12 inhibitor: a single ascending dose study in healthy humans.
    Asai F; Jakubowski JA; Naganuma H; Brandt JT; Matsushima N; Hirota T; Freestone S; Winters KJ
    Platelets; 2006 Jun; 17(4):209-17. PubMed ID: 16769598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients.
    Pulcinelli FM; Pignatelli P; Celestini A; Riondino S; Gazzaniga PP; Violi F
    J Am Coll Cardiol; 2004 Mar; 43(6):979-84. PubMed ID: 15028353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of ticlopidine on the natural course of retinal vein occlusion.
    Houtsmuller AJ; Vermeulen JA; Klompe M; Zahn KJ; Henkes HE; Baarsma GS; Tijssen J
    Agents Actions Suppl; 1984; 15():219-29. PubMed ID: 6385648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention.
    Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C
    Am J Cardiol; 2006 Jan; 97(1):38-43. PubMed ID: 16377281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ticlopidine in China: comparative study on the effect of two dose levels on bleeding time and platelet function in healthy volunteers.
    Ruan C; Destelle G; Wang Z; Wan H; He Y; Cheng D; Li P; Duffas M
    Haemostasis; 1989; 19(2):94-9. PubMed ID: 2731781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiplatelet effects of ticlopidine are reduced in experimental hypercholesterolemia.
    Hohlfeld T; Scharnowski F; Braun M; Schrör K
    Thromb Haemost; 1994 Jan; 71(1):112-8. PubMed ID: 7513092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clopidogrel-induced platelet inhibition cannot be detected by the platelet function analyzer-100 system in stroke patients.
    Kotzailias N; Elwischger K; Sycha T; Rinner W; Quehenberger P; Auff E; Müller C
    J Stroke Cerebrovasc Dis; 2007; 16(5):199-202. PubMed ID: 17845916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiplatelet drugs and thrombosis prevention: ticlopidine in perspective.
    de Gaetano G; Bertelé V
    Arq Bras Cardiol; 1983 Dec; 41(6):425-7. PubMed ID: 6678584
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative effect of antiplatelet therapy in retinal vein occlusion evaluated by the particle-counting method using light scattering.
    Yamamoto T; Kamei M; Yokoi N; Yasuhara T; Tei M; Kinoshita S
    Am J Ophthalmol; 2004 Nov; 138(5):809-17. PubMed ID: 15531317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists.
    Zucker ML; Budd SE; Dollar LE; Chernoff SB; Altman R
    Thromb Haemost; 1993 Aug; 70(2):332-5. PubMed ID: 8236144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
    Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE
    J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention.
    Hochholzer W; Trenk D; Frundi D; Blanke P; Fischer B; Andris K; Bestehorn HP; Büttner HJ; Neumann FJ
    Circulation; 2005 May; 111(20):2560-4. PubMed ID: 15809367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges in oral antiplatelet therapy: ST-segment elevation myocardial infarction.
    Dauerman HL
    Am J Cardiol; 2009 Sep; 104(5 Suppl):39C-43C. PubMed ID: 19695360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the antiplatelet effects of prasugrel and high-dose clopidogrel as assessed by VASP-phosphorylation and light transmission aggregometry.
    Jakubowski JA; Payne CD; Li YG; Farid NA; Brandt JT; Small DS; Salazar DE; Winters KJ
    Thromb Haemost; 2008 Jan; 99(1):215-22. PubMed ID: 18217157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiplatelet effects of piplartine, an alkamide isolated from Piper tuberculatum: possible involvement of cyclooxygenase blockade and antioxidant activity.
    Fontenele JB; Leal LK; Silveira ER; Felix FH; Bezerra Felipe CF; Viana GS
    J Pharm Pharmacol; 2009 Apr; 61(4):511-5. PubMed ID: 19298699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study.
    Angiolillo DJ; Shoemaker SB; Desai B; Yuan H; Charlton RK; Bernardo E; Zenni MM; Guzman LA; Bass TA; Costa MA
    Circulation; 2007 Feb; 115(6):708-16. PubMed ID: 17261652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic and pharmacological interactions between ticlopidine hydrochloride and Kangen-Karyu - Chinese traditional herbal medicine.
    Makino T; Wakushima H; Okamoto T; Okukubo Y; Deguchi Y; Kano Y
    Phytother Res; 2003 Nov; 17(9):1021-4. PubMed ID: 14595580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.